[The effect of Suisynchron on the glucose tolerance and the plasma insulin in bitches].
Suisynchron, a derivative of bisthio-urea commonly used for oestric synchronisation, was applied to nine female Alsatians over 21 days. All animals received intravenous glucose injections before ten, and 21 days from the beginning of treatment as well as 21, and 84 days after the end of treatment. The glucose-stimulated plasma insulin levels were significantly reduced during Suisynchron treatment and 21 days after the end of treatment. Both glucose tolerance and response of free fatty acids remained unaffected. This phenomenon might be attributable to a stimulated hepatic insulin degradation, to a biguanid-like effect on "peripheral" glucose turnover, or to an inhibited secretion of hormonal insulin antagonists of the anterior lobe of the pituitary gland. However, the long persistence of the Suisynchron action after interruption of treatment, could not be explained by any of these effects.
D000818:Animals; D004285:Dogs; D004973:Estrus Synchronization / Q000187:drug effects; D005260:Female; D005951:Glucose Tolerance Test / Q000662:veterinary; D007328:Insulin / Q000097:blood*; D011247:Pregnancy; D013890:Thiourea / Q000494:pharmacology*
D007328:Insulin; D013890:Thiourea
Zum Einfluss von Suisynchron auf Glukosetoleranz und Plasma-insulin bei Hündinnen.